Title

Co-formulated favezelimab plus pembrolizumab versus standard-of-care in previously treated, PD-L1-positive metastatic colorectal cancer: The phase 3, randomized KEYFORM-007 study.

Authors

Segal, Neil Howard; Passhak, Maria; Köse, Fatih; Kubala, Eugen; Elez, Elena; Kawakami, Hisato; Guren, Marianne G.; Jonker, Derek J.; Xu, Rui-Hua; Riera, Jorge; Tortora, Giampaolo; Siena, Salvatore; Yeh, Yu-Min; Yusof, Mastura Md; Shiu, Kai-Keen; Starling, Naureen; Peng, Xiang; Fogelman, David R.; Adelberg, David E.; Kim, Tae Won

Publication

Journal of Clinical Oncology, 2025, Vol 43, pLBA248

ISSN

0732-183X

Publication type

Academic Journal

DOI

10.1200/JCO.2025.43.4_suppl.LBA248